首页 >
法规速递
-
国家药监局关于修订甲氨蝶呤口服制剂说明书的公告（2022年第100号）-2022/11/4
2022-11-14查看详情 > -
国家药监局关于发布仿制药参比制剂目录 （第六十五批）的通告（2023年第15号）-2023/03/14
2023-03-14查看详情 > -
Draft Guidance: Alternative Tools: Assessing Drug Manufacturing Facilities Identified in Pending Applications-2023/9/21
2023-09-22查看详情 > -
Page: PRIME: priority medicines-2025/1/6
2025-01-07查看详情 > -
国家药监局关于发布仿制药参比制剂目录（第九十批）的通告（2025年第9号）-2025/2/12
2025-02-12查看详情 > -
Document: Clinical Trial Information System (CTIS) structured data form - Initial application, additional Member State Concerned, substantial modification, non-substantial modification-2025/3/18
2025-03-19查看详情 > -
Document: Business process description for PSUSA and other related post-authorisation processes-2025/4/22
2025-04-23查看详情 > -
Document: Agenda of the PRAC meeting 2-5 June 2025-2025/6/2
2025-06-03查看详情 > -
Document: Minutes of the CHMP meeting 24-27 February 2025-2025/7/8
2025-07-09查看详情 > -
Page: Pre-authorisation guidance-2025/8/12
2025-08-13查看详情 >
